An official website of the United States government
Publication Information
Affiliation
University of California San Francisco, San Francisco, CA mandana.khalili@ucsf.edu.; University of Washington, Seattle, WA.; University of Pittsburgh, Pittsburgh, PA.; University of Toronto, Toronto, Ontario, Canada.; National Institutes of Health, Bethesda, MD.; Massachusetts General Hospital, Boston, MA.; University of California San Francisco, San Francisco, CA.; Washington University School of Medicine in St. Louis, St. Louis, MO.; Virginia Commonwealth University, Richmond, VA.; University of Michigan, Ann Arbor, MI.
Authors
Khalili Mandana, Shuhart Margaret C, Lombardero Manuel, Feld Jordan J, Kleiner David E, Chung Raymond T, Terrault Norah A, Lisker-Melman Mauricio, Sanyal Arun, Lok Anna S
Studies
Abstract
Metabolic syndrome (MS) is prevalent and is associated with adverse outcomes of liver disease. We evaluated the prevalence of MS and its influence on alanine aminotransferase (ALT) levels and fibrosis, as estimated by the aspartate aminotransferase-to-platelet ratio index (APRI), in a large, multiethnic North American cohort with chronic hepatitis B (HBV) infection.